NI
GILD icon

NDVR Inc’s Gilead Sciences GILD Stock Holding History

NDVR Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$374K Sell
3,047
-137
-4% -$16.6K 0.31% 30
2025
Q3 		$353K Buy
3,184
+16
+0.5% +$1.82K 0.29% 43
2025
Q2 		$351K Buy
3,168
+256
+9% +$27.2K 0.33% 40
2025
Q1 		$326K Buy
2,912
+601
+26% +$62K 0.33% 40
2024
Q4 		$213K Buy
+2,311
New +$208K 0.2% 94
2024
Q2 		– Sell
-2,739
Closed -$201K – 98
2024
Q1 		$201K Sell
2,739
-47
-2% -$3.61K 0.19% 102
2023
Q4 		$226K Buy
+2,786
New +$217K 0.27% 47

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NDVR Inc's GILD Position: Q4 2025 in Review

NDVR Inc reduced its Gilead Sciences (GILD) stake by 4.3% in Q4 2025, selling an estimated $16.6K and leaving 3,047 shares worth $374K. The position accounts for 0.31% of the portfolio, ranked #30.

NDVR Inc first reported a position in GILD in Q4 2023 and has held it in 7 quarters since. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • NDVR Inc held 3,047 shares of Gilead Sciences worth $374K as of Q4 2025.
  • NDVR Inc sold 137 Gilead Sciences shares in Q4 2025, an estimated $16.6K.
  • Gilead Sciences made up 0.31% of NDVR Inc's portfolio in Q4 2025, its #30 holding.
  • NDVR Inc first reported a position in Gilead Sciences in Q4 2023 and has held it in 7 quarters since.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on NDVR Inc's 13F filing for Q4 2025, filed 12 Feb 2026.